top stonk selection for permabulls hello all
time for some light fun :d
stonks only go up- this one must have 200x upside!
welcome to the infinite liquidity basket :D
Indaptus Therapeutics, Inc.
No trades
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−24.82 USD
−20.85 M USD
0.00 USD
28.24 K
About Indaptus Therapeutics, Inc.
Sector
Industry
CEO
Jun Yi Dai
Website
Headquarters
New York
Identifiers
3
ISIN US45339J2042
Indaptus Therapeutics, Inc. is a clinical biotechnology company. The firm engages in the development of a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It created patented treatment methods and associated patented compositions for attenuation and killing of non-pathogenic, Gram-negative bacteria. The company was founded by Michael James Newman on February 24, 2021 and is headquartered in New York, NY.
Related stocks
INDPIndaptus Therapeutics Inc (NASDAQ:INDP) Over 25% of INDP's tradable shares are in the hands of short sellers, meaning they sold the stock and are holding for further declines. Unlike buying a stock, when you can only lose as much as you invest, a short seller's loss potential is unlimited, which is
Long
INDPIndaptus Therapeutics, Inc. (INDP) is setting up for a possible breakout, which based on the chart could send the stock up like a rocket. The RSI14 at 40 and the MACD is still curling upward. Chart on Breakout Watch.
Long
mid term +700%Indaptus Therapeutics, Inc., a pre-clinical stage biotech company, develops a patented anti-cancer and antiviral immunotherapy.
INDPIndaptus Therapeutics Inc (NASDAQ:INDP) The company's 13D filing on Friday after hours showed that Michael J. Newman had reported a stake of 25.7% in the company. The filing came out later in the session, so I think the stock should see a nice bump when it opens for trade on Monday. With such a low
Long
See all ideas
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently asked questions
The current price of INDP is 1.75 USD — it has increased by 1.16% in the past 24 hours. Watch Indaptus Therapeutics, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Indaptus Therapeutics, Inc. stocks are traded under the ticker INDP.
INDP stock has fallen by −14.63% compared to the previous week, the month change is a −16.67% fall, over the last year Indaptus Therapeutics, Inc. has showed a −85.08% decrease.
INDP reached its all-time high on Sep 26, 2017 with the price of 21,952.00 USD, and its all-time low was 1.51 USD and was reached on Apr 6, 2026. View more price dynamics on INDP chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
INDP stock is 6.98% volatile and has beta coefficient of 4.66. Track Indaptus Therapeutics, Inc. stock price on the chart and check out the list of the most volatile stocks — is Indaptus Therapeutics, Inc. there?
Today Indaptus Therapeutics, Inc. has the market capitalization of 3.92 M, it has decreased by −7.30% over the last week.
Yes, you can track Indaptus Therapeutics, Inc. financials in yearly and quarterly reports right on TradingView.
Indaptus Therapeutics, Inc. is going to release the next earnings report on May 14, 2026. Keep track of upcoming events with our Earnings Calendar.
INDP net income for the last quarter is −8.11 M USD, while the quarter before that showed −2.98 M USD of net income which accounts for 0.00% change. Track more Indaptus Therapeutics, Inc. financial stats to get the full picture.
No, INDP doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of May 14, 2026, the company has 5 employees. See our rating of the largest employees — is Indaptus Therapeutics, Inc. on this list?
Like other stocks, INDP shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Indaptus Therapeutics, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Indaptus Therapeutics, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Indaptus Therapeutics, Inc. stock shows the sell signal. See more of Indaptus Therapeutics, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.